Diclofenac in Translational Inflammation Research: Mechan...
2025-10-21
This thought-leadership article dissects the mechanistic underpinnings and strategic applications of Diclofenac, a non-selective COX inhibitor, in the context of advanced inflammation and pharmacokinetic research. Drawing from cutting-edge organoid science and integrating evidence from recent stem cell-derived intestinal organoid studies, it delivers actionable insights for translational researchers seeking to bridge mechanistic discovery, competitive innovation, and clinical relevance in anti-inflammatory drug development.